{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02330978",
      "OrgStudyIdInfo": {
        "OrgStudyId": "HCRP 14151/2010"
      },
      "Organization": {
        "OrgFullName": "University of Sao Paulo",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.",
      "OfficialTitle": "Intravitreal Autologous Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Advanced Glaucoma. Phase I: Safety Study."
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2019",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 2014"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2016",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 2016",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "December 31, 2014",
      "StudyFirstSubmitQCDate": "December 31, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 5, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "ResultsFirstSubmitDate": "April 16, 2019",
      "ResultsFirstSubmitQCDate": "April 16, 2019",
      "ResultsFirstPostDateStruct": {
        "ResultsFirstPostDate": "July 8, 2019",
        "ResultsFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "April 16, 2019",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 8, 2019",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "JAYTER SILVA DE PAULA",
        "ResponsiblePartyInvestigatorTitle": "Associate Professor",
        "ResponsiblePartyInvestigatorAffiliation": "University of Sao Paulo"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Sao Paulo",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Conselho Nacional de Desenvolvimento Científico e Tecnológico",
            "CollaboratorClass": "OTHER_GOV"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Bone marrow-derived mesenchymal stem cells (MSC) therapy is a promising treatment for several degenerative diseases, including retinopathies and glaucoma, however no previous safety study involving humans has been conducted. The objective of this study is to evaluate effects of autologous bone marrow-derived MSC transplantation in the worst eye of 10 patients with legal bilateral blindness due to glaucoma. Primary outcome are types and severity of adverse effects. Secondary outcomes are changes in visual field, visual acuity, optical coherence tomography, and retinal ganglion cells function."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Retinal Degeneration",
          "Primary Open-angle Glaucoma"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "2",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSC transplantion",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "One group of glaucomatous patients will receive 10(6) autologous bone marrow-derived mesenchymal stem cells transplantation into their worst eyes, through an unique intravitreal injections, under anesthesia.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: Intravitreal transplantation of mesenchymal stem cell",
                "Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "Intravitreal transplantation of mesenchymal stem cell",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC transplantion"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Culture and isolation of autologous bone-marrow mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC transplantion"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Type and Severity of Adverse Effects (AE) and Adverse Reactions (AR)",
            "PrimaryOutcomeDescription": "Retinal detachment",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Changes in Visual Acuity",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Changes in Visual Field",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Changes in Optical Coherence Tomography Parameters Related to Glaucoma",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Changes in Retinal Ganglion Cells Function by ERG",
            "SecondaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of Advanced Bilateral Open-Angle Glaucoma;\nBest corrected visual acuity less than 0,1 in the better eye;\nSocial and cognitive ability to participate.\n\nExclusion Criteria:\n\nSevere systemic morbidities;\nOther ocular blind conditions associated;\nImpossibility in performing any of the proposed examinations.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "40 Years",
      "MaximumAge": "90 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Jayter S Paula, MD",
            "OverallOfficialAffiliation": "Associate Professor",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Ribeirão Preto Medical School",
            "LocationCity": "Ribeirao Preto",
            "LocationState": "Sao Paulo",
            "LocationZip": "14049900",
            "LocationCountry": "Brazil"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "33469852",
            "ReferenceType": "derived",
            "ReferenceCitation": "Vilela CAP, Messias A, Calado RT, Siqueira RC, Silva MJL, Covas DT, Paula JS. Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma. Doc Ophthalmol. 2021 Aug;143(1):33-38. doi: 10.1007/s10633-021-09817-z. Epub 2021 Jan 19."
          }
        ]
      }
    }
  },
  "ResultsSection": {
    "ParticipantFlowModule": {
      "FlowPreAssignmentDetails": "The study requisits to enroll patients are too tight and some patients selected do not atend to all admision requisits like vision acuity worse than 20/100 in both eyes, absence of systemic comorbidities, etc.",
      "FlowGroupList": {
        "FlowGroup": [
          {
            "FlowGroupId": "FG000",
            "FlowGroupTitle": "MSC Transplantion",
            "FlowGroupDescription": "One group of glaucomatous patients will receive 10(6) autologous bone marrow-derived mesenchymal stem cells transplantation into their worst eye, through an unique intravitreal injections, under anesthesia.\n\nIntravitreal transplantation of mesenchymal stem cell\n\nCulture and isolation of autologous bone-marrow mesenchymal stem cells"
          }
        ]
      },
      "FlowPeriodList": {
        "FlowPeriod": [
          {
            "FlowPeriodTitle": "The First Patient Included at Study",
            "FlowMilestoneList": {
              "FlowMilestone": [
                {
                  "FlowMilestoneType": "STARTED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "1"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "1"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "NOT COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "FlowPeriodTitle": "The Second Patient Included at Study",
            "FlowMilestoneList": {
              "FlowMilestone": [
                {
                  "FlowMilestoneType": "STARTED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "1"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "1"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "NOT COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "0"
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "BaselineCharacteristicsModule": {
      "BaselineGroupList": {
        "BaselineGroup": [
          {
            "BaselineGroupId": "BG000",
            "BaselineGroupTitle": "The First Patient Included at Study",
            "BaselineGroupDescription": "On the thirtieth day after the vitreous injection a combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - promptly treated with a successful pars plana vitrectomy and silicone oil tamponade. At the final follow-up period (12 months), he remained with no retinal detachment and light perception vision."
          }
        ]
      },
      "BaselineDenomList": {
        "BaselineDenom": [
          {
            "BaselineDenomUnits": "Participants",
            "BaselineDenomCountList": {
              "BaselineDenomCount": [
                {
                  "BaselineDenomCountGroupId": "BG000",
                  "BaselineDenomCountValue": "2"
                }
              ]
            }
          }
        ]
      },
      "BaselineMeasureList": {
        "BaselineMeasure": [
          {
            "BaselineMeasureTitle": "Age, Categorical",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "<=18 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Between 18 and 65 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "1"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": ">=65 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "1"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Sex: Female, Male",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineMeasureCalculatePct": "No",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Female",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Male",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "2"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Region of Enrollment",
            "BaselineMeasureParamType": "Number",
            "BaselineMeasureUnitOfMeasure": "participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineClassTitle": "Brazil",
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "2"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "OutcomeMeasuresModule": {
      "OutcomeMeasureList": {
        "OutcomeMeasure": [
          {
            "OutcomeMeasureType": "Primary",
            "OutcomeMeasureTitle": "Type and Severity of Adverse Effects (AE) and Adverse Reactions (AR)",
            "OutcomeMeasureDescription": "Retinal detachment",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "6 months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "The First Patient Included at Study",
                  "OutcomeGroupDescription": "On the thirtieth day after the vitreous injection a combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - promptly treated with a successful pars plana vitrectomy and silicone oil tamponade. At the final follow-up period (12 months), he remained with no retinal detachment and light perception vision."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "1"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "1"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Changes in Visual Acuity",
            "OutcomeMeasureReportingStatus": "Not Posted",
            "OutcomeMeasureTimeFrame": "6 months",
            "OutcomeMeasureDenomUnitsSelected": "Participants"
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Changes in Visual Field",
            "OutcomeMeasureReportingStatus": "Not Posted",
            "OutcomeMeasureTimeFrame": "6 months",
            "OutcomeMeasureDenomUnitsSelected": "Participants"
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Changes in Optical Coherence Tomography Parameters Related to Glaucoma",
            "OutcomeMeasureReportingStatus": "Not Posted",
            "OutcomeMeasureTimeFrame": "6 months",
            "OutcomeMeasureDenomUnitsSelected": "Participants"
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Changes in Retinal Ganglion Cells Function by ERG",
            "OutcomeMeasureReportingStatus": "Not Posted",
            "OutcomeMeasureTimeFrame": "6 months",
            "OutcomeMeasureDenomUnitsSelected": "Participants"
          }
        ]
      }
    },
    "AdverseEventsModule": {
      "EventsFrequencyThreshold": "0",
      "EventGroupList": {
        "EventGroup": [
          {
            "EventGroupId": "EG000",
            "EventGroupTitle": "The First Patient Included at Study",
            "EventGroupDescription": "On the thirtieth day after the vitreous injection a combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - promptly treated with a successful pars plana vitrectomy and silicone oil tamponade. At the final follow-up period (12 months), he remained with no retinal detachment and light perception vision.",
            "EventGroupSeriousNumAffected": "1",
            "EventGroupSeriousNumAtRisk": "2",
            "EventGroupOtherNumAffected": "0",
            "EventGroupOtherNumAtRisk": "2"
          }
        ]
      },
      "SeriousEventList": {
        "SeriousEvent": [
          {
            "SeriousEventTerm": "Retinal detachment",
            "SeriousEventOrganSystem": "Eye disorders",
            "SeriousEventNotes": "A combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - treated with vitrectomy and silicone oil tamponade. At the final follow-up period he remained with no retinal detachment and light perception vision.",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "2"
                }
              ]
            }
          }
        ]
      }
    },
    "MoreInfoModule": {
      "CertainAgreement": {
        "AgreementPISponsorEmployee": "Yes"
      },
      "PointOfContact": {
        "PointOfContactTitle": "Jayter Silva de Paula, MD, PhD",
        "PointOfContactOrganization": "University São Paulo",
        "PointOfContactEMail": "jspaula@fmrp.usp.br",
        "PointOfContactPhone": "55 16 3602-2499"
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000005901",
            "ConditionMeshTerm": "Glaucoma"
          },
          {
            "ConditionMeshId": "D000005902",
            "ConditionMeshTerm": "Glaucoma, Open-Angle"
          },
          {
            "ConditionMeshId": "D000012162",
            "ConditionMeshTerm": "Retinal Degeneration"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000009798",
            "ConditionAncestorTerm": "Ocular Hypertension"
          },
          {
            "ConditionAncestorId": "D000005128",
            "ConditionAncestorTerm": "Eye Diseases"
          },
          {
            "ConditionAncestorId": "D000015785",
            "ConditionAncestorTerm": "Eye Diseases, Hereditary"
          },
          {
            "ConditionAncestorId": "D000012164",
            "ConditionAncestorTerm": "Retinal Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8165",
            "ConditionBrowseLeafName": "Glaucoma",
            "ConditionBrowseLeafAsFound": "Glaucoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8166",
            "ConditionBrowseLeafName": "Glaucoma, Open-Angle",
            "ConditionBrowseLeafAsFound": "Primary Open Angle Glaucoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14149",
            "ConditionBrowseLeafName": "Retinal Degeneration",
            "ConditionBrowseLeafAsFound": "Retinal Degeneration",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9176",
            "ConditionBrowseLeafName": "Hypertension",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11883",
            "ConditionBrowseLeafName": "Ocular Hypertension",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7423",
            "ConditionBrowseLeafName": "Eye Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M17491",
            "ConditionBrowseLeafName": "Eye Diseases, Hereditary",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14151",
            "ConditionBrowseLeafName": "Retinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC11",
            "ConditionBrowseBranchName": "Eye Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M3259",
            "InterventionBrowseLeafName": "Anesthetics",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "CNSDep",
            "InterventionBrowseBranchName": "Central Nervous System Depressants"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}